2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Algenpantucel-L: new trials by email Literature Review of Algenpantucel-L trials Research Report on Algenpantucel-L
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Behavioral Intervention for PrEP Service Utilization Among Chinese MSM: A HAPA and CEI Integrated Model HAPA and CEI behavioral intervention, HAPA-based intervention - HIV, PrEP | Not applicable | Not yet recruiting | Peking University | 360 | 2025-07-01 | 2025-06-04 |
| Immunotherapy Study for Surgically Resected Pancreatic Cancer HyperAcute-Pancreas Immunotherapy, Gemcitabine, 5FU Chemoradiation - Pancreatic Cancer | Phase 3 | Completed | NewLink Genetics Corporation | 722 | 2010-04-01 | 2020-05-28 |
| Vaccine Treatment for Surgically Resected Pancreatic Cancer HyperAcute-Pancreatic Cancer Vaccine - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | NewLink Genetics Corporation | 7 | 2005-11-01 | 2020-05-28 |
Pancreatic Neoplasms (2) · Homosexuality (1)
NewLink Genetics Corporation (2) · Peking University (1)
United States (2)
Mary Mulcahy, M.D. (1) · Wangnan Cao, Ph.D (1)